Literature DB >> 10936677

Methylation of a CpG island within the promoter region of the KAI1 metastasis suppressor gene is not responsible for down-regulation of KAI1 expression in invasive cancers or cancer cell lines.

P Jackson1, D Millar, E Kingsley, G Yardley, K Ow, S Clark, P J Russell.   

Abstract

The molecular basis for downregulation of the KAI1 metastasis suppressor gene in invasive and metastatic human cancers is unknown. We have used bisulphite methylation analysis of DNA from paraffin-embedded invasive bladder tumour samples and from bladder cancer cell lines to determine if hypermethylation of a CpG island within the KAI1 promoter is responsible for this effect. Representative invasive tumour cell lines were also exposed to 5-aza-2-deoxycytidine. We found no evidence for hypermethylation of the CpG island and suggest that mechanisms other than promoter hypermethylation are responsible for reduced KAI1 expression in invasive bladder tumours and tumour cell lines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10936677     DOI: 10.1016/s0304-3835(00)00483-3

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  14 in total

Review 1.  Tetraspanins: push and pull in suppressing and promoting metastasis.

Authors:  Margot Zöller
Journal:  Nat Rev Cancer       Date:  2008-12-11       Impact factor: 60.716

2.  KAI1 metastasis suppressor gene is frequently down-regulated in cervical carcinoma.

Authors:  F S Liu; J T Chen; J T Dong; Y T Hsieh; A J Lin; E S Ho; M J Hung; C H Lu
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

3.  KAI1 gene is engaged in NDRG1 gene-mediated metastasis suppression through the ATF3-NFkappaB complex in human prostate cancer.

Authors:  Wen Liu; Megumi Iiizumi-Gairani; Hiroshi Okuda; Aya Kobayashi; Misako Watabe; Sudha K Pai; Puspa R Pandey; Fei Xing; Koji Fukuda; Vishnu Modur; Shigeru Hirota; Kazuyuki Suzuki; Toshimi Chiba; Masaki Endo; Tamotsu Sugai; Kounosuke Watabe
Journal:  J Biol Chem       Date:  2011-03-21       Impact factor: 5.157

Review 4.  Dissecting the diverse functions of the metastasis suppressor CD82/KAI1.

Authors:  Yien Che Tsai; Allan M Weissman
Journal:  FEBS Lett       Date:  2011-08-27       Impact factor: 4.124

Review 5.  Genetic basis of human breast cancer metastasis.

Authors:  M T Debies; D R Welch
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-10       Impact factor: 2.673

6.  Phorbol ester enhances KAI1 transcription by recruiting Tip60/Pontin complexes.

Authors:  Alexandra Rowe; Jörg Weiske; Tobias S Kramer; Otmar Huber; Paul Jackson
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

7.  Methylation of a CpG island within the uroplakin Ib promoter: a possible mechanism for loss of uroplakin Ib expression in bladder carcinoma.

Authors:  Andrea E Varga; Lefta Leonardos; Paul Jackson; Alexandra Marreiros; Prue A Cowled
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715

8.  Nm23-H1 was involved in regulation of KAI1 expression in high-metastatic lung cancer cells L9981.

Authors:  Jiacong You; Rui Chang; Bin Liu; Lingling Zu; Qinghua Zhou
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

9.  Methylation impact analysis of erythropoietin (EPO) Gene to hypoxia inducible factor-1α (HIF-1α) activity.

Authors:  Firli Rahmah Primula Dewi; Fatchiyah Fatchiyah
Journal:  Bioinformation       Date:  2013-08-28

10.  KAI-1 and p53 expression in oral squamous cell carcinomas: Markers of significance in future diagnostics and possibly therapeutics.

Authors:  Namrata N Patil; Vijay Wadhwan; Minal Chaudhary; Abhishek Singh Nayyar
Journal:  J Oral Maxillofac Pathol       Date:  2016 Sep-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.